Clinical Trial Update: 125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on 125I seed implantation plus systemic therapy for oligoprogressive non-small cell lung cancer or colorectal cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Li Min | Conditions: Oligometastatic Disease | Phase 2 | Status: NOT_YET_RECRUITING